Intrexon | XON - EPS Earnings Per Share


Intrexon reported $-0.1 in EPS Earnings Per Share for its fiscal quarter ending in June of 2024.





Eps Change Date
Agenus USD -0.3 0.84 Dec/2025
Alaunos Therapeutics USD -0.53 0.08 Sep/2025
Amgen USD 5.15 0.14 Mar/2026
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
AstraZeneca USD 2.58 0.46 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Gilead Sciences USD 1.86 0.61 Dec/2025
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Incyte USD 1.81 0.01 Mar/2026
Intrexon USD -0.1 0.03 Jun/2024
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
Ligand Pharmaceuticals USD 2.02 1.07 Dec/2025
MacroGenics USD -0.22 0.49 Dec/2025
MannKind USD 0.01 0.06 Dec/2025
Merck USD -1.28 3.32 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Roche Holding CHF 8.37 2.95 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Thermo Fisher Scientific USD 5.44 1.13 Mar/2026
Veracyte USD 0.52 0.01 Mar/2026
Xencor USD -0.09 0.01 Dec/2025